UHMK1 and posterior cortical atrophy: Moreover, Kaplan–Meier analysis of our single-center cohort study involving 112 patients indicated that PCa patients with higher levels of UHMK1 had poorer biochemical recurrence (BCR)-free survival (Fig. 1J).